QGEN - Qiagen N.V.

NYSE - NYSE Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
2,141,518
2,141,518
2,251,657
1,870,346
1,526,424
Cost of revenue
756,955
756,955
800,837
642,536
521,162
Gross profit
1,384,563
1,384,563
1,450,820
1,227,810
1,005,262
Operating expenses
Research development
189,859
189,859
189,964
139,060
157,448
Selling general and administrative
603,945
603,945
584,468
544,311
504,168
Total operating expenses
808,335
808,335
792,974
682,941
691,589
Operating income or loss
576,228
576,228
657,846
544,869
313,673
Interest expense
58,357
58,357
54,477
73,002
74,185
Total other income/expenses net
-38,027
-38,027
12,909
-326,972
-339,377
Income before tax
512,601
512,601
625,833
154,927
-77,776
Income tax expense
89,390
89,390
113,234
81,287
-36,321
Income from continuing operations
423,211
423,211
512,599
73,640
-41,455
Net income
423,211
423,211
512,599
73,640
-41,455
Net income available to common shareholders
423,211
423,211
512,599
73,640
-41,455
Basic EPS
-
1.86
2.26
0.32
-0.18
Diluted EPS
-
1.84
2.21
0.31
-0.18
Basic average shares
-
227,716
227,074
228,427
227,752
Diluted average shares
-
230,136
232,034
234,214
232,420
EBITDA
-
779,355
895,241
437,900
227,867